NEA

Tony Florence and Mohamad Makhzoumi Named Co-CEOs of NEA; Scott Sandell Assumes Role of Executive Chairman & CIO

Retrieved on: 
Tuesday, April 9, 2024
Finance, Consulting, Banking, Professional Services, Asset Management, CIO, Growth, Executive, VGE, NEA, Sandell, Multimedia, Management

In conjunction with their appointments, Scott Sandell will assume the full-time role of Executive Chairman and Chief Investing Officer.

Key Points: 
  • In conjunction with their appointments, Scott Sandell will assume the full-time role of Executive Chairman and Chief Investing Officer.
  • All three will continue to actively invest, with Sandell’s new role also signifying an enhanced day-to-day focus on company building and team mentorship.
  • View the full release here: https://www.businesswire.com/news/home/20240409483634/en/
    Tony Florence and Mohamad Makhzoumi Named Co-CEOs of NEA; Scott Sandell Assumes Role of Executive Chairman & CIO.
  • (Photo: Business Wire)
    “Tony and Mohamad are exceptional leaders who have been shaping key aspects of NEA’s strategy and operations for many years.

Lily AI Closes $20M Series B-1 Funding Round

Retrieved on: 
Thursday, March 14, 2024
E-commerce, ROI, Lilium, General partnership, J.Crew, AI, Housing, Yoy, Engineering, Commerce, Traction, NEA, Abercrombie & Fitch, ALC

The Lily AI Series B-Prime investment comes 18 months after its initial Series B round; customers have quadrupled during that time resulting from adoption of the Company’s core product attribution platform as well as generative AI solutions such as the recently announced content generation product.

Key Points: 
  • The Lily AI Series B-Prime investment comes 18 months after its initial Series B round; customers have quadrupled during that time resulting from adoption of the Company’s core product attribution platform as well as generative AI solutions such as the recently announced content generation product.
  • Raised at a premium to its last financing, Lily AI will use this latest funding round to extend its leadership into international markets, expand its social and eCommerce platform integrations, and accelerate the engineering team’s ability to ship enterprise-grade AI solutions across the retail value chain.
  • “There is tremendous momentum in the market and we are seeing increased demand from retailers looking to leverage proven AI to enhance customer experiences and improve business efficiency,” said Purva Gupta, Co-founder and Chief Executive Officer, Lily AI.
  • “We’ve benefitted from visionary and supportive investors from day one and are fortunate to continue that trend with Conductive Ventures leading this latest round.

Pyxis Oncology Expands Board of Directors with Appointment of Santhosh Palani, Ph.D., CFA

Retrieved on: 
Wednesday, March 13, 2024
Research, Takeda Pharmaceutical Company, IO, Biotechnology, PFM, University, Patient, Columbia University, Cowen Inc., Doctor of Philosophy, Biochemistry, New Enterprise Associates, CFA, Cancer, Texas A&M University, Pfizer, Chemical engineering, Drug development, NEA, Therapy, ADC, Pharmaceutical industry

BOSTON, March 13, 2024 (GLOBE NEWSWIRE) -- Pyxis Oncology, Inc. (Nasdaq: “PYXS”), a clinical stage company focused on developing next generation therapeutics to target difficult-to-treat cancers, today announced the appointment of Santhosh Palani, Ph.D., CFA, to its board of directors, effective March 12, 2024.

Key Points: 
  • BOSTON, March 13, 2024 (GLOBE NEWSWIRE) -- Pyxis Oncology, Inc. (Nasdaq: “PYXS”), a clinical stage company focused on developing next generation therapeutics to target difficult-to-treat cancers, today announced the appointment of Santhosh Palani, Ph.D., CFA, to its board of directors, effective March 12, 2024.
  • “We are thrilled to have Santhosh join the Pyxis Oncology board.
  • Santhosh brings a wealth of business, investment, strategic, and board experience to our team,” said Lara S. Sullivan, M.D., President and Chief Executive Officer of Pyxis Oncology.
  • "I am delighted to join the Board of Directors at Pyxis Oncology at such a pivotal moment in the Company's journey as they anticipate data readouts for their lead ADC program, PYX-201, and their IO program, PYX-106, in 2024," said Dr. Santhosh Palani.

Avenzo Therapeutics Announces $150 Million Oversubscribed Financing To Advance Emerging Oncology Pipeline

Retrieved on: 
Tuesday, March 26, 2024
Oncology, Health, Clinical Trials, General Health, Pharmaceutical, Biotechnology, Private equity, CDK2, Patient, Foresite Capital, Eli Lilly and Company, New Enterprise Associates, Therapy, OrbiMed, NEA, OncoMed, Pharmaceutical industry

(“Avenzo”), a clinical-stage biotechnology company developing next generation oncology therapeutics, today announced the closing of an oversubscribed $150 million Series A-1 financing.

Key Points: 
  • (“Avenzo”), a clinical-stage biotechnology company developing next generation oncology therapeutics, today announced the closing of an oversubscribed $150 million Series A-1 financing.
  • The total capital raised since the company’s founding in August 2022 is $347 million.
  • In conjunction with the announcement, Jakob Dupont, M.D., Executive Partner, Private Equity, Sofinnova Investments, will join the Avenzo Board of Directors.
  • “The team at Avenzo has made great progress over the past 18 months since formation on our mission to advance the next generation of oncology therapies for patients,” said Athena Countouriotis, M.D., Co-founder, President and CEO of Avenzo.

Foundry Raises $80 Million in Seed and Series A Funding to Build a New Breed of Public Cloud

Retrieved on: 
Thursday, March 21, 2024
Internet, Data Management, Technology, Artificial Intelligence, Software, Deep learning, Computational biology, GPU, LG, Speed of light, MIT, Databricks, Pear VC, AI, Stanford University, Conviction, Civilization, M12 (venture capital), Lightspeed Venture Partners, Ecosystem, NEA, KKR, Economics, Sequoia Capital

Today, Foundry , a new breed of public cloud for AI/ML workloads, announced $80M in seed and Series A funding to orchestrate the world’s compute capacity, rendering it universally accessible and useful.

Key Points: 
  • Today, Foundry , a new breed of public cloud for AI/ML workloads, announced $80M in seed and Series A funding to orchestrate the world’s compute capacity, rendering it universally accessible and useful.
  • Foundry is building to ensure humanity maximizes the utility of the computing power we already have, and will produce.
  • Foundry’s innovative methods are solving these issues by providing scalable GPU instances with unmatched price-performance ratios.
  • If you are interested in becoming a customer or partner, or joining the team, please visit the company’s website .

NEA Appoints Lila Tretikov Partner, Head of AI Strategy

Retrieved on: 
Wednesday, March 13, 2024
Professional Services, Business, Technology, Finance, Asset Management, Artificial Intelligence, Foundation (nonprofit), CIO, Microsoft, GTM, Volvo, Organization, IPP, Growth, Wikimedia Foundation, Lila Tretikov, Woman, Intelligence, United, San Francisco Chronicle, Databricks, SugarCRM, Knowledge, Ethics, Climate, United Nations, Xylem, Entrepreneurship, AI, University, Planning, Biology, Robotics, Engineering, NEA, Perception, Engie, Car, Stanford University, Multimedia, Medicine, Management

New Enterprise Associates, Inc. (NEA) announced today that Lila Tretikov has joined the firm as Partner, Head of AI Strategy.

Key Points: 
  • New Enterprise Associates, Inc. (NEA) announced today that Lila Tretikov has joined the firm as Partner, Head of AI Strategy.
  • In her newly created role at NEA, Tretikov will spearhead the firm’s strategy to advance AI innovation, adoption and implementation across its portfolio and investing practices, as well as pursue new investment opportunities.
  • View the full release here: https://www.businesswire.com/news/home/20240313803759/en/
    NEA Appoints Lila Tretikov Partner, Head of AI Strategy (Photo: Business Wire)
    “Lila is a leading global AI expert with an extraordinary depth of knowledge, from the most esoteric technical details to productization to its sweeping impact on humanity.
  • Earlier in her career, Tretikov founded several companies in the U.S. and Europe that went public or were successfully acquired.

Frazier Healthcare Partners Announces Acquisition of RevSpring

Retrieved on: 
Tuesday, March 12, 2024
Professional Services, Payments, Health, Technology, Finance, General Health, ROI, Growth, Communication, Partnership, Frazier Healthcare Partners, LLP, Acquisition, Capital, Morgan Stanley, NEA, GTCR

Frazier Healthcare Partners (Frazier), a Seattle-based, healthcare-focused investment firm, announced today that it has completed its acquisition of RevSpring (“RevSpring” or the “Company”), a leading provider of end-to-end communication and payment solutions servicing healthcare and financial services companies, from leading private equity firm GTCR.

Key Points: 
  • Frazier Healthcare Partners (Frazier), a Seattle-based, healthcare-focused investment firm, announced today that it has completed its acquisition of RevSpring (“RevSpring” or the “Company”), a leading provider of end-to-end communication and payment solutions servicing healthcare and financial services companies, from leading private equity firm GTCR.
  • RevSpring helps customers accelerate revenue and increase engagement through an intelligent digital platform that includes omnichannel communication, payments, and analytic tools.
  • “We are excited about RevSpring’s next chapter of growth in partnership with Frazier,” said Scott MacKenzie, CEO of RevSpring.
  • Kirkland & Ellis LLP served as legal counsel to RevSpring, and Goodwin Proctor LLP served as legal counsel to Frazier.

NEW RESEARCH FINDS ADULTS, CHILDREN AND TEENS WITH ECZEMA EXPERIENCE SIGNIFICANT MENTAL HEALTH SYMPTOMS

Retrieved on: 
Wednesday, March 27, 2024
Research, Depression, Atopic dermatitis, Mental, Caregiver, Patient, CQD, Mental health, Child, Anxiety, Dermatitis, Flare, Pleasure, NEA, Emotion, Nursing

NOVATO, Calif., March 27, 2024 /PRNewswire/ -- The National Eczema Association (NEA) today announced the first publication from its real-world research on eczema and its impacts on mental health. The results were published in the journal Dermatitis in March 2024.

Key Points: 
  • In a new study, the NEA research team aimed to evaluate patient-reported mental health symptoms, their correlation with eczema severity, and patient-perceived associations of eczema and its impacts on mental health.
  • The survey included questions about eczema symptoms, mental health symptoms, perceptions of the connection between eczema and mental health, and experiences accessing mental health services.
  • The study findings illustrated that adults, children and teens with eczema experience a significant mental health burden that increases with eczema severity:
    70% of respondents reported that either their own or their child's mental health was impacted by eczema during the past year.
  • Those with more severe eczema symptoms were more likely to have 10+ days of poor mental health than those with less severe eczema symptoms.

Biodiesel Market Analysis Forecasts Significant Growth 2024-2030: Global Insights on Trends, Industry Expansion and Top Companies

Retrieved on: 
Thursday, March 21, 2024
Electricity, Ethanol, USDA, B40, Palm oil, Application, Gasoline, FAME, Insight, Statistics, EPA, NEA, Smog, Government, SAF, Renewable energy

DUBLIN, March 21, 2024 /PRNewswire/ -- The "Biodiesel Market, Size, Share, Global Forecast 2024-2030, Industry Trends, Growth, Insight, Top Companies Analysis" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • DUBLIN, March 21, 2024 /PRNewswire/ -- The "Biodiesel Market, Size, Share, Global Forecast 2024-2030, Industry Trends, Growth, Insight, Top Companies Analysis" report has been added to ResearchAndMarkets.com's offering.
  • The global biodiesel market is projected to boom at a CAGR of 6.05% between 2024 and 2030, to reach US$ 59.26 billion by 2030.
  • Moreover, increasing manufacturing meets the rising demand, bolstering the global biodiesel market by presenting more sustainable fuel options and mitigating reliance on fossil fuels.
  • Besides, government assistance for renewable energy tasks is contributing to the boom of the global biodiesel market.

The National Eczema Association Approved for $250,000 Engagement Award from PCORI

Retrieved on: 
Monday, March 18, 2024
CER, Communication, Eugene Washington, Patient, Research, Quality of life, Nature, Dermatitis, MBS, Investment, MPH, Way, NEA, FDA, Nursing

NOVATO, Calif., March 18, 2024 /PRNewswire/ -- The National Eczema Association (NEA) has been approved for a $250,000 funding award through the Eugene Washington PCORI Engagement Award Program, an initiative of the Patient-Centered Outcomes Research Institute (PCORI). The award will support a project titled "Paving the Way towards Meaningful Partnerships: Fostering Regional PCOR to Enhance Eczema Outcomes." The award period spans two years, from February 1, 2024 through Jan 31, 2026.

Key Points: 
  • NOVATO, Calif., March 18, 2024 /PRNewswire/ -- The National Eczema Association (NEA) has been approved for a $250,000 funding award through the Eugene Washington PCORI Engagement Award Program, an initiative of the Patient-Centered Outcomes Research Institute (PCORI).
  • The award will support a project titled "Paving the Way towards Meaningful Partnerships: Fostering Regional PCOR to Enhance Eczema Outcomes."
  • The PCORI Engagement Award will be directed by co-project leads Wendy Smith Begolka, MBS, chief strategy officer at NEA and Jessica K. Johnson, MPH, director of community engagement at NEA.
  • For more information on the PCORI Engagement Award and NEA's funded project, visit here .